Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov 19;9(11):827.
doi: 10.3390/antibiotics9110827.

Phage Therapy: Towards a Successful Clinical Trial

Andrzej Górski  1   2   3 , Jan Borysowski  4 , Ryszard Międzybrodzki  1   2   4
Affiliations

Phage Therapy: Towards a Successful Clinical Trial

Andrzej Górski et al. Antibiotics (Basel). .

Abstract

While phage therapy carried out as compassionate use (experimental therapy) has recently flourished, providing numerous case reports of supposedly healed patients, clinical trials aiming to formally prove their value in accord with current regulatory requirements have failed. In light of the current issue of increasing antibiotic resistance, the need for a final say regarding the place of phage therapy in modern medicine is evident. We analyze the possible factors that may favor success or lead to the failure of phage therapy: quality of phage preparations, their titer and dosage, as well as external factors that could also contribute to the outcome of phage therapy. Hopefully, better control of these factors may eventually bring about long-awaited positive results.

Keywords: antibiotic resistance; clinical trial; phage therapy.

PubMed Disclaimer

Conflict of interest statement

A. Górski, R. Międzybrodzki and J. Borysowski are co-inventors of patents owned by the Hirszfeld Institute of Immunology and Experimental Therapy.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Leitner L., Ujmajuridze A., Chanishvili N., Goderdzishvili M., Chkonia I., Rigvava S., Chkhotua A., Changashvili G., McCallin S., Schneider M.P., et al. Intravesical bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: A randomised, placebo-controlled, double-blind clinical trial. Lancet Infect. Dis. 2020:1473. doi: 10.1016/S1473-3099(20)30330-3. - DOI - PubMed
    1. Pirnay J.-P., Kutter E. Bacteriophages: It’s a medicine, Jim, but not as we know it. Lancet Infect. Dis. 2020:1473. doi: 10.1016/s1473-3099(20)30464-3. - DOI - PubMed
    1. Alam Sarker S., Sultana S., Reuteler G., Moine D., Descombes P., Charton F., Bourdin G., McCallin S., Ngom-Bru C., Neville T., et al. Oral Phage Therapy of Acute Bacterial Diarrhea With Two Coliphage Preparations: A Randomized Trial in Children From Bangladesh. EBioMedicine. 2016;4:124–137. doi: 10.1016/j.ebiom.2015.12.023. - DOI - PMC - PubMed
    1. Jault P., Leclerc T., Jennes S., Pirnay J.-P., Que Y.-A., Resch G., Rousseau A.F., Ravat F., Carsin H., Le Floch R., et al. Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): A randomised, controlled, double-blind phase 1/2 trial. Lancet Infect. Dis. 2019;19:35–45. doi: 10.1016/S1473-3099(18)30482-1. - DOI - PubMed
    1. Worley-Morse T.O., Zhang L., Gunsch C.K. The long-term effects of phage concentration on the inhibition of planktonic bacterial cultures. Environ. Sci. Process. Impacts. 2014;16:81–87. doi: 10.1039/C3EM00427A. - DOI - PubMed

LinkOut - more resources